# Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models

> **NCT06366932** · PHASE4 · UNKNOWN · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 150 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Second-line systemic treatment
- **OTHER:** Folllow-up of second-line systemic treatment already started

## Key facts

- **NCT ID:** NCT06366932
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-25
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06366932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06366932, "Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06366932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*